Treatment for ulcerative colitis differs based on the individual. Where the inflammation occurs, the severity, and the preference of the patient can all influence the treatment. For those with moderate…
The 27th United European Gastroenterology Week took place in Barcelona, Spain in October, at which some of the leading experts in gastroenterology spoke about their field. One of the…
New developments in drugs and technology have greatly improved treatment for a variety of diseases, one of them being inflammatory bowel disease. These developments have bettered the lives of…
A new study has found that young people who have inflammatory bowel disease (IBD) are five times more likely to develop an infection than the general population. They also…
In a meeting with some of the world's brightest medical minds, the importance of personalized treatment for inflammatory bowel disease was discussed. At the 14th Annual Congress of the…
Speakers: Joseph Cappa, M.D. Jennifer, living with severe CD Learn More About a Treatment Option for Adults with Moderate to Severe Ulcerative Colitis and Crohn’s Disease Register to attend a…
According to a story from Medical Xpress, an international team of scientist from 34 different countries are putting their heads together to identify the most effective treatments for ulcerative colitis,…
A recent article in Medical Life Science News reports that a recent study has discovered a new mechanism that interacts with an immune cell receptor called Mincle. This receptor regulates…
According to a story from Medical News Bulletin, a recent study that was first published in the New England Journal of Medicine appears to have revealed a promising new treatment for ulcerative…
Speakers: Emily Ankrom, PA-C, Digestive Specialists Dan, living with moderate CD Learn More About a Treatment Option for Adults with Moderate to Severe Ulcerative Colitis and Crohn’s Disease Register to…
The drugs for current inflammatory bowel disease (IBD) patients only help around 50% of patients. And some who do find relief find it short lived as remissions often occur.…
As originally reported in Cambridge Independent, inflammatory bowel diseases are about to get a boost in research after Health Data Research UK has awarded a £5 million grant to a…
.jpg)
The Providence Journal recently published an article by Brittany Ricci, a student at Brown University’s Alpert Medical School, detailing her year-long struggle to receive the treatment her doctor had prescribed…
Speakers: Laura Larson, PA-C, Western Washington Medical Group Michelle, living with moderate CD Learn More About a Treatment Option for Adults with Moderate to Severe Ulcerative Colitis and Crohn’s Disease…
Speakers: Michele Kissous-Hunt, PA, Fifth Avenue GI Michelle, living with moderate CD Learn More About a Treatment Option for Adults with Moderate to Severe Ulcerative Colitis and Crohn’s Disease Register…
Bob Hussey Bob Hussey is a 62-year-old mechanical engineer who, thanks to his own experience as an ulcerative colitis patient, has created a new invention that could help a wide…
According to a story from BioSpace, Janssen Pharmaceutical Companies recently announced that the European Commission (EC) has expanded the approved indication of the company's drug ustekinumab (marketed as Stelara). This…
According to a story from health.usnews.com, a flareup of symptoms can be a time of serious distress for patients with ulcerative colitis, which is a rare type of inflammatory bowel…
According to a press release from French biotechnology company Abivax, the Company has successfully begun recruitment for its phase 2b clinical study of ABX464, its experimental once-a-day ulcerative colitis medication.…
According to a press release from the German-American biotechnology company Immunic Therapeutics, the Company recently began a proof-of-concept trial for its investigational primary sclerosing cholangitis treatment, IMU-838. About Primary Sclerosing…
According to a story from EurekAlert!, a team of researchers affiliated with UT Southwestern were successfully able to curtail inflammation-associated colorectal cancer in mice by precisely editing the animals' gut…
In a story reported in the Boston Globe, Stephen Marcus, as a person with Crohn’s disease, knows the laws surrounding bathroom policies from public franchises. He worked as a lawyer…
Inflammatory Bowel Disease Inflammatory bowel disease (IBD) is actually a term used to classify a few different conditions. Two of these are Crohn's disease and ulcerative colitis. These are rare…
As reported in EurekAlert, an exciting new treatment method has entered the conversation to treat inflammatory bowel disease (IBD). Researchers have successfuly used mice population to show that precision cutting…
According to a story from Ankylosing Spondylitis News, the drug Hadlima, which is a biosimilar to the drug Humira (adalimumab), was recently approved by the US Food and Drug Administration…
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
